Article Text

PDF
HMGA1 overexpression is associated with a particular subset of human breast carcinomas
  1. Romina Sepe1,
  2. Salvatore Piscuoglio2,3,
  3. Cristina Quintavalle2,
  4. Valeria Perrina2,
  5. Luca Quagliata2,
  6. Umberto Formisano1,
  7. Luigi Maria Terracciano2,
  8. Alfredo Fusco1,4,
  9. Pierlorenzo Pallante1
  1. 1Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS) “G. Salvatore”, Consiglio Nazionale delle Ricerche (CNR), Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), Università degli Studi di Napoli “Federico II”, Naples, Italy
  2. 2Molecular Pathology Division, Institute of Pathology, University of Basel, Basel, Switzerland
  3. 3Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
  4. 4Instituto Nacional de Câncer—INCA, Rua André Cavalcanti, 37-Centro, Rio de Janeiro, Brazil
  1. Correspondence to Dr Alfredo Fusco, Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), Università degli Studi di Napoli “Federico II”, Via S. Pansini 5, Naples 80131, Italy; alfusco{at}unina.it

Abstract

Objectives Breast cancer represents the second leading cause of cancer mortality among American women and accounts for more than 40 000 deaths annually. High-mobility group A1 (HMGA1) expression has been implicated in the pathogenesis and progression of human malignant tumours, including breast carcinomas. The aim of this study was to evaluate HMGA1 detection as an indicator for the diagnosis and prognosis of human breast carcinoma.

Methods HMGA1 expression has been analysed by immunohistochemistry in a large series of breast carcinoma resections (1338) combined on a tissue microarray mainly including the ductal carcinoma variant. The results were then correlated with clinicopathological parameters of patients.

Results HMGA1 overexpression was found in the large majority of breast carcinoma samples and its overexpression positively correlated with HER-2/neu amplification and progesterone receptor, while a negative correlation was found with oestrogen receptor. Conversely, no HMGA1 expression was found in normal breast tissues.

Conclusions The data reported here indicate that HMGA1 is overexpressed in human breast carcinomas and its levels are associated with a particular endocrine status.

  • BREAST CANCER
  • IMMUNOHISTOCHEMISTRY
  • CARCINOMA

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.